biotricity: How Wearables Are Poised To Transform Medicine

Technology is revolutionizing our understanding and treatment of disease, according to a recently released McKinsey & Company article.

And, with the number of people being diagnosed with cardiovascular disease (CVD) accelerating at an alarming rate – beyond what our healthcare infrastructure can adequately manage – clinically accurate monitoring devices may provide a solution.

Healthcare is necessarily evolving to emphasize preventive care in an effort to mitigate the rising demand that the growing CVD population is placing on our system. However, traditional methods are failing to ensure CVD patients comply with their physicians' medical directives (medication, changes to diet, exercise, etc.).

"There is a gaping hole in the healthcare IT marketplace where most solutions lack medical relevancy," says Waqaas Al-Siddiq, Founder, President and CEO of biotricity, a healthcare technology company. "Technology needs to be utilized to create innovative, clinically accurate solutions that drive individuals to self manage their chronic conditions and reduce, if not avoid, the impact of such illnesses in the first place."

Waqaas Al-Siddiq is available to the media for comment on the gap in the healthcare marketplace and how his company is leveraging technology to create innovative, medically relevant solutions to drive individuals to self-manage their chronic conditions.

Please see McKinsey & Company's Insights & Publications article for additional reference.